The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10 code N85. 00 for Endometrial hyperplasia, unspecified is a medical classification as listed by WHO under the range - Diseases of the genitourinary system .
N85. 00 - Endometrial hyperplasia, unspecified | ICD-10-CM.
621.33 - Endometrial hyperplasia with atypia | ICD-10-CM.
Endometrial hyperplasia thickens the uterus lining, causing heavy or abnormal bleeding. Atypical endometrial hyperplasia raises the risk of endometrial cancer and uterine cancer. The condition tends to occur during or after menopause. Progestin therapy can ease symptoms.
89 Abnormal findings on diagnostic imaging of other specified body structures.
Endometrial Hyperplasia: A condition in which the lining of the uterus grows too thick. Endometrial Intraepithelial Neoplasia (EIN): A precancerous condition in which areas of the lining of the uterus grow too thick.
621.31 - Simple endometrial hyperplasia without atypia | ICD-10-CM.
Atypical hyperplasia is a precancerous condition that affects cells in the breast. Atypical hyperplasia describes an accumulation of abnormal cells in the milk ducts and lobules of the breast. Atypical hyperplasia isn't cancer, but it increases the risk of breast cancer.
Endometrial intraepithelial neoplasia [EIN] The 2022 edition of ICD-10-CM N85. 02 became effective on October 1, 2021.
If an endometrial thickness of ≥ 8 mm is considered abnormal, 0.9% of women without cancer and without bleeding and 12% of women without cancer and with bleeding will have endometrial measurements above this threshold, and 95% of women with cancer will have endometrial measurements above this threshold.
Endometrial hyperplasia occurs when the cells in the uterine lining grow rapidly and/or excessively, but unlike with endometriosis, the lining stays inside the uterus. Mild or simple hyperplasia, the most common type, has a very small risk of becoming cancerous.
These types are: simple endometrial hyperplasia, complex endometrial hyperplasia, simple atypical endometrial hyperplasia, and complex atypical endometrial hyperplasia.
A benign condition in which tissue that looks like endometrial tissue grows in abnormal places in the abdomen. A condition in which functional endometrial tissue is present outside the uterus. It is often confined to the pelvis involving the ovary, the ligaments, cul-de-sac, and the uterovesical peritoneum.
It can grow on the ovaries, behind the uterus or on the bowels or bladder. Rarely, it grows in other parts of the body. This "misplaced" tissue can cause pain, infertility, and very heavy periods.
Endometrial hyperplasia is a condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #742-743 - Uterine and adnexa procedure for non-malignancy with CC or MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code N85.01. Click on any term below to browse the alphabetical index.